Acorda Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acorda Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q1 2024.
  • Acorda Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $3.94M, a 21.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $3.94M -$1.09M -21.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.22M -$1.07M -20.2% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $4.5M -$1.05M -18.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.77M -$1.03M -17.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $5.03M -$587K -10.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.29M -$1.46M -21.7% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $5.54M -$2.32M -29.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.79M -$3.16M -35.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $5.62M -$4.4M -43.9% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $6.75M -$11.7M -63.5% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $7.86M -$11.9M -60.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $8.95M -$12.2M -57.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $10M -$12.4M -55.4% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $18.5M -$4.97M -21.2% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $19.8M -$4.87M -19.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $21.2M -$4.71M -18.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $22.5M -$4.35M -16.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $23.5M Dec 31, 2019 10-K 2021-03-16
Q3 2019 $24.7M Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $25.9M Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $26.8M Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.